HEADER 13-OCT-06 2IQ2 TITLE BCL-2L10 COMPND MOL_ID: 1; COMPND 2 MOLECULE: METHIONINE; COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES KEYWDS BCL-2L10, ANTI-APOPTOTIC PROTEIN TRANSMEMBRANE PROTEIN KEYWDS 2 APOPTOSIS EXPDTA THEORETICAL MODEL AUTHOR BHARGAVI KONDAGARI,KALYAN CHAITANYA PULIPAKA,RAMAKRISHNA AUTHOR 2 ANNABHIMOJU,UMA VURUPUTURI,K.MURTHY DWARKANATH REVDAT 1 24-OCT-06 2IQ2 0 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SCHRODINGER 2005 REMARK 3 AUTHORS : D.E.SHAW REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2IQ2 COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 13-OCT-2006. REMARK 100 THE RCSB ID CODE IS RCSB039875. REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT REMARK 220 VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT REMARK 220 CONFORM TO THE PDB FORMAT. REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 888 REMARK 888 WRITTEN BY MAESTRO (A PRODUCT OF SCHRODINGER, LLC) SEQRES 1 194 MET ALA ASP PRO LEU ARG GLU ARG THR GLU LEU LEU LEU SEQRES 2 194 ALA ASP TYR LEU GLY TYR CYS ALA ARG GLU PRO GLY THR SEQRES 3 194 PRO GLU PRO ALA PRO SER THR PRO GLU ALA ALA VAL LEU SEQRES 4 194 ARG SER ALA ALA ALA ARG LEU ARG GLN ILE HIS ARG SER SEQRES 5 194 PHE PHE SER ALA TYR LEU GLY TYR PRO GLY ASN ARG PHE SEQRES 6 194 GLU LEU VAL ALA LEU MET ALA ASP SER VAL LEU SER ASP SEQRES 7 194 SER PRO GLY PRO THR TRP GLY ARG VAL VAL THR LEU VAL SEQRES 8 194 THR PHE ALA GLY THR LEU LEU GLU ARG GLY PRO LEU VAL SEQRES 9 194 THR ALA ARG TRP LYS LYS TRP GLY PHE GLN PRO ARG LEU SEQRES 10 194 LYS GLU GLN GLU GLY ASP VAL ALA ARG ASP CYS GLN ARG SEQRES 11 194 LEU VAL ALA LEU LEU SER SER ARG LEU MET GLY GLN HIS SEQRES 12 194 ARG ALA TRP LEU GLN ALA GLN GLY GLY TRP ASP GLY PHE SEQRES 13 194 CYS HIS PHE PHE ARG THR PRO PHE PRO LEU ALA PHE TRP SEQRES 14 194 ARG LYS GLN LEU VAL GLN ALA PHE LEU SER CYS LEU LEU SEQRES 15 194 THR THR ALA PHE ILE TYR LEU TRP THR ARG LEU LEU HELIX 1 1 MET 1 ARG 22 1 22 HELIX 2 2 LEU 39 HIS 50 1 12 HELIX 3 3 LEU 58 ARG 64 1 7 HELIX 4 4 PHE 65 VAL 75 1 11 HELIX 5 5 SER 79 PHE 93 1 15 HELIX 6 6 GLU 99 TRP 108 1 10 HELIX 7 7 GLY 112 GLY 122 1 11 HELIX 8 8 VAL 124 GLN 142 1 19 HELIX 9 9 ARG 144 GLN 150 1 7 HELIX 10 10 TRP 153 PHE 160 1 8 HELIX 11 11 ARG 170 TYR 188 1 19 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MASTER 28 0 0 11 0 0 0 6 0 0 0 15 END